401 related articles for article (PubMed ID: 19182485)
1. A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
Larney S; Dolan K
Eur Addict Res; 2009; 15(2):107-12. PubMed ID: 19182485
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine use: the international experience.
Carrieri MP; Amass L; Lucas GM; Vlahov D; Wodak A; Woody GE
Clin Infect Dis; 2006 Dec; 43 Suppl 4():S197-215. PubMed ID: 17109307
[TBL] [Abstract][Full Text] [Related]
3. Regarding naltrexone for probationers and parolees.
Stancliff S
J Subst Abuse Treat; 2007 Mar; 32(2):217-8; author reply 218-9. PubMed ID: 17306730
[No Abstract] [Full Text] [Related]
4. Opioid substitution therapy--a study of GP participation in prescribing.
Scarborough J; Eliott J; Braunack-Mayer A
Aust Fam Physician; 2011 Apr; 40(4):241-5. PubMed ID: 21597537
[TBL] [Abstract][Full Text] [Related]
5. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Roux P; Carrieri MP; Villes V; Dellamonica P; Poizot-Martin I; Ravaux I; Spire B;
Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
[TBL] [Abstract][Full Text] [Related]
6. Role of buprenorphine in the management of heroin addiction.
Sung S; Conry JM
Ann Pharmacother; 2006 Mar; 40(3):501-5. PubMed ID: 16434562
[TBL] [Abstract][Full Text] [Related]
7. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.
Sullivan LE; Metzger DS; Fudala PJ; Fiellin DA
Addiction; 2005 Feb; 100(2):150-8. PubMed ID: 15679744
[TBL] [Abstract][Full Text] [Related]
8. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
[TBL] [Abstract][Full Text] [Related]
9. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Spire B; Lucas GM; Carrieri MP
Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
[TBL] [Abstract][Full Text] [Related]
10. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
Lawrinson P; Ali R; Buavirat A; Chiamwongpaet S; Dvoryak S; Habrat B; Jie S; Mardiati R; Mokri A; Moskalewicz J; Newcombe D; Poznyak V; Subata E; Uchtenhagen A; Utami DS; Vial R; Zhao C
Addiction; 2008 Sep; 103(9):1484-92. PubMed ID: 18636999
[TBL] [Abstract][Full Text] [Related]
11. Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
Favrod-Coune T; Baroudi M; Casillas A; Rieder JP; Gétaz L; Barro J; Gaspoz JM; Broers B; Wolff H
Swiss Med Wkly; 2013; 143():w13898. PubMed ID: 24186493
[TBL] [Abstract][Full Text] [Related]
12. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
Gisev N; Shanahan M; Weatherburn DJ; Mattick RP; Larney S; Burns L; Degenhardt L
Addiction; 2015 Dec; 110(12):1975-84. PubMed ID: 26212260
[TBL] [Abstract][Full Text] [Related]
13. Contemporary methods in pharmacotherapy in the opiate dependent treatment.
Radomska M; Bisaga A; Popik P
Przegl Lek; 2000; 57(10):509-18. PubMed ID: 11199877
[TBL] [Abstract][Full Text] [Related]
14. [Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis].
Levasseur L; Marzo JN; Ross N; Blatier C
Ann Med Interne (Paris); 2002 May; 153(3 Suppl):1S14-9. PubMed ID: 12218878
[TBL] [Abstract][Full Text] [Related]
15. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
Marzo JN; Rotily M; Meroueh F; Varastet M; Hunault C; Obradovic I; Zin A
Addiction; 2009 Jul; 104(7):1233-40. PubMed ID: 19426291
[TBL] [Abstract][Full Text] [Related]
16. Prisoners who inject drugs: public health and human rights imperatives.
Jürgens R; Betteridge G
Health Hum Rights; 2005; 8(2):46-74. PubMed ID: 17136903
[TBL] [Abstract][Full Text] [Related]
17. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
Mammen K; Bell J
Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849
[TBL] [Abstract][Full Text] [Related]
18. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
[No Abstract] [Full Text] [Related]
19. Prescribing Opioid Replacement Therapy in U.S. Correctional Settings.
Farahmand P; Modesto-Lowe V; Chaplin MM
J Am Acad Psychiatry Law; 2017 Dec; 45(4):472-477. PubMed ID: 29282239
[TBL] [Abstract][Full Text] [Related]
20. [Opioid substitution therapy in France: a physician's overview].
Michel L
Ann Pharm Fr; 2009 Sep; 67(5):369-73. PubMed ID: 19695374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
